Hologic to Showcase Breast Tomosynthesis Technology and Other Product Innovations at ECR in Vienna

BEDFORD, Mass., Feb. 25, 2013 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, will display an extensive suite of healthcare solutions for breast cancer screening and diagnosis, breast biopsy, osteoporosis risk assessment, medical MRI coils, and extremity imaging at the annual meeting of the European Society of Radiology, in Vienna, Austria March 7 – 11. The European Congress of Radiology (ECR), the largest radiological meeting in Europe, annually attracts over 20,000 participants representing the medical specialty of radiology throughout Europe and many other countries of the world.

"All eyes in the radiology community are on Vienna in March and the five-day European Congress of Radiology," said David Harding , Hologic's Senior Vice President and General Manager, International. "We believe this will be an exceptionally exciting time to reach out to the radiology world with our newest innovations in imaging. Of particular interest this year are advances in our breast tomosynthesis program, including the introduction of a tomosynthesis biopsy option for our Affirm breast biopsy guidance system. In addition, a significant number of peer-reviewed papers have been accepted by major scientific journals, including the recent publication of the results of the Oslo Breast Tomosynthesis Screening Trial. This and other publications continue to build support for the benefits of Hologic's breast tomosynthesis - improved accuracy compared to conventional mammography, resulting in earlier detection of cancers and a reduced need for recalls."

source: PR Newswire

Digirad Corporation Launches Molecular Breast Imaging Accessory for Expanded Use of ergo™ Imaging System

POWAY, CA -- (Marketwire) -- 02/21/13 -- Digirad Corporation (NASDAQ: DRAD), a leading provider of diagnostic imaging products, and personnel and equipment leasing services, today announced the launch of their Molecular Breast Imaging Accessory for the ergo™ Imaging System, further expanding the clinical flexibility of the ergo™ Imaging System for applications in the area of women's health, as well as in nuclear medicine where the ergo™ Imaging System is currently used for a wide variety of clinical applications.

The introduction of Digirad's Molecular Breast Imaging Accessory follows the U.S. FDA 510(k) market clearance recently received for expanded use of the ergo™ Imaging System, which includes Indications for Use to aid in the evaluation of lesions in the breast and other small body parts. When used for breast imaging, the ergo™ Imaging System can be used as an adjunct to mammography or other primary breast imaging modalities.

Digirad Chief Executive Officer Todd Clyde noted that this launch marks another key step in the company's strategy to expand its imaging technology footprint in the hospital through the use of flexible, portable systems with devices that have expanded diagnostics capabilities.

"We believe the Molecular Breast Imaging Accessory fills an important market need and is a natural addition to the ergo™ Imaging System," said Clyde. "Advanced diagnostic modalities are often necessary to help clinicians identify lesions in the breast, and our new Molecular Breast Imaging Accessory provides this capability. It is a cost-effective, non-dedicated option for molecular breast imaging that enhances the clinical capabilities and operational efficiencies of the ergo™ Imaging System."

source: DigiRad

Faxitron Introduces New Surgical Specimen Container

TUCSON, Ariz., Feb. 12, 2013 /PRNewswire-iReach/ -- Faxitron, the leading developer, manufacturer and supplier of dedicated digital specimen radiography systems expands their solution for intraoperative imaging of breast specimens with the introduction of the Faxitron® Wedge™, a revolutionary new surgical specimen container. The Wedge™ is designed to work in conjunction with the Faxitron® BioVision, allowing surgeons to quickly and simply image the specimen from multiple views, without compromising image quality, facilitating better gross margin assessment and potentially lowering re-excision rates.

Clinical findings have illustrated the importance of radiographically marking the tissue specimen and utilizing two orthogonal views to significantly reduce re-excision rates during breast conservation surgery. Intra-operative specimen radiography has become a common practice in most breast programs. However, obtaining orthogonal views is not widely practiced, predominately because there has not been a consistent, reliable means of performing this in the surgical suite.

source: PR Newswire

Morris Gad Praises Research in Breast Cancer Detection Methods

NEW YORK, Feb. 6, 2013 /PRNewswire-iReach/ -- Medical News Today has released an article detailing new research that has improved breast cancer detection rates. According to the report, "Three-dimensional mammography combined with conventional breast imaging can increase breast cancer detection by 27 percent." Morris Gad, who is involved in many philanthropies and supports such research, congratulates researchers on their findings and encourages future initiatives to continue to build upon the success that today's studies have achieved.

The article explains that the research was conducted by experts working at the University of Olso in Norway. Originally, the results of their efforts were published in "Radiology," a scholarly journal. In addition to the findings listed above, the study found that false-positives were decreased by 15 percent when using the combined three-dimensional mammography, or tomosynthesis, alongside traditional imaging practices.

source: PR Newswire

MDH Radiology selects Sectra for nationwide telemammography solution

MDH Radiology, through its unique and comprehensive delivery model, will utilize Sectra Breast Imaging PACS to provide remote reading of mammograms to its customers according to a recently signed agreement with the international medical imaging IT company, Sectra (Link) (STO: SECT B).

The agreement also includes integrated breast density software provided by VolparaTM, digital reporting software and Breast Cancer Risk profiles by PenRadTM and Merge Healthcare’s CADstreamTM for breast MRI readings. Via a multi-tiered service offering, MDH Radiology will assist healthcare providers to bridge the gap in their existing breast imaging and biopsy services.

“It is time for all women to have access to consistent, high-quality breast care regardless of their geographic region,” says MDH Radiology Founder and President, Dr. Hurvitz. “There is a disparity in access to critical screening and diagnostic services in many areas of the country that is unacceptable. My mission is to connect women everywhere with the outstanding quality of care they deserve when it comes to their breast health. ”

source: Secta